Evidence map›Paper›PMID 32670891›Full record

ArticleFrontiers in cellular and infection microbiology2020

Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay.

Charlotte J Houldcroft, Sarah E Jackson, Eleanor Y Lim, George X Sedikides, Emma L Davies, Claire Atkinson, Megan McIntosh, Ester B M Remmerswaal, Georgina Okecha, Frederike J Bemelman and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. An Adagio for Viruses, Played Out on Ancient DNA.Genome biology and evolution · 2023
    Review
  10. IL-10-Secreting CD8Pathogens (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Charlotte J HouldcroftDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
Sarah E JacksonDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
Eleanor Y LimDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
George X SedikidesDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
Emma L DaviesDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
Claire AtkinsonDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Megan McIntoshDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Ester B M RemmerswaalDepartment of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Georgina OkechaDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
Frederike J BemelmanDepartment of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Richard J StantonDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Matthew ReevesDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Mark R WillsDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
Addenbrooke's Hospital · GBUniversity College London · GBUniversity of Amsterdam · NLUniversity of Cambridge · GBCardiff University · GB

Funding

Department of HealthMedical Research Council MR/K021087/1Medical Research Council MR/L008734/1Medical Research Council MR/S00081X/1Medical Research Council MR/S00971X/1Wellcome Trust 204870/Z/16/Z
6 · The paper itself

Abstract

HCMV infection, reinfection or reactivation occurs in 60% of untreated solid organ transplant (SOT) recipients. Current clinical approaches to HCMV management include pre-emptive and prophylactic antiviral treatment strategies. The introduction of immune monitoring to better stratify patients at risk of viraemia and HCMV mediated disease could improve clinical management. Current approaches quantify T cell IFNγ responses specific for predominantly IE and pp65 proteins

Indexed as

CytomegalovirusTransplant RecipientsCD8-Positive T-LymphocytesHumansImmunity, CellularLeukocytes, MononuclearMembrane GlycoproteinsMembrane Glycoproteinsantiviralcell-mediated immunitycytomegalovirusherpesvirushost-pathogen interactionssecreted immunityT cellstransplantation

Identifiers

PMID32670891
PMCPMC7332694
OpenAlexW3024888207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.